Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Nav1.8 sodium channel with efficacy in a model of neuropathic pain

被引:30
|
作者
Scanio, Marc J. C. [1 ]
Shi, Lei [1 ]
Drizin, Irene [1 ]
Gregg, Robert J. [1 ]
Atkinson, Robert N. [2 ]
Thomas, James B. [2 ]
Johnson, Matthew S. [2 ]
Chapman, Mark L. [2 ]
Liu, Dong [2 ]
Krambis, Michael J. [2 ]
Liu, Yi [2 ]
Shieh, Char-Chang [1 ]
Zhang, XuFeng [1 ]
Simler, Gricelda H. [1 ]
Joshi, Shailen [1 ]
Honore, Prisca [1 ]
Marsh, Kennan C. [1 ]
Knox, Alison [1 ]
Werness, Stephen [2 ]
Antonio, Brett [2 ]
Krafte, Douglas S. [2 ]
Jarvis, Michael F. [1 ]
Faltynek, Connie R. [1 ]
Marron, Brian E. [2 ]
Kort, Michael E. [1 ]
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
[2] Icagen Inc, Durham, NC 27703 USA
关键词
Sodium channels; Na(v)1.8; PN3; Neuropathic pain; DERIVATIVES; NOMENCLATURE; EXPRESSION; A-803467; NEURONS; ASSAY;
D O I
10.1016/j.bmc.2010.09.057
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Na(v)1.8 (also known as PN3) is a tetrodotoxin-resistant (TTx-r) voltage-gated sodium channel (VGSC) that is highly expressed on small diameter sensory neurons. It has been implicated in the pathophysiology of inflammatory and neuropathic pain, and we envisioned that selective blockade of Na(v)1.8 would be analgesic, while reducing adverse events typically associated with non-selective VGSC blocking therapeutic agents. Herein, we describe the preparation and characterization of a series of 6-aryl-2-pyrazinecarboxamides, which are potent blockers of the human Na(v)1.8 channel and also block TTx-r sodium currents in rat dorsal root ganglia (DRG) neurons. Selected derivatives display selectivity versus human Na(v)1.2. We further demonstrate that an example from this series is orally bioavailable and produces antinociceptive activity in vivo in a rodent model of neuropathic pain following oral administration. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7816 / 7825
页数:10
相关论文
共 10 条
  • [1] Discovery and pharmacological evaluation of potent, selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic pain
    Kort, Michael E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [2] Potent, selective pyrazine-based blockers of the Nav1.8 (PN3) sodium channel
    Scanio, Marc J. C.
    Shi, Lei
    Kort, Michael E.
    Drizin, Irene
    Gregg, Robert J.
    Thomas, James B.
    Atkinson, Robert N.
    Johnson, Matthew S.
    Marron, Brian E.
    Chapman, Mark L.
    Liu, Dong
    Krambis, Michael J.
    Su, Xin
    Shieh, Char-Chang
    Zhang, XuFeng
    Hernandez, Gricelda
    Joshi, Shailen
    Honore, Prisca
    Marsh, Kennan C.
    Knox, Alison
    Werness, Stephen
    Krafte, Douglas S.
    Jarvis, Michael F.
    Faltynek, Connie R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 825 - 825
  • [3] MEDI 321-Potent, selective pyrazine-based blockers of the Nav1.8 (PN3) sodium channel
    Wang, Guijun
    Nie, Xiaoping
    Hopkinson, Branden
    Cheuk, Sherwin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 941 - 941
  • [4] Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain
    Kort, Michael E.
    Drizin, Irene
    Gregg, Robert J.
    Scanio, Marc J. C.
    Shi, Lei
    Gross, Michael F.
    Atkinson, Robert N.
    Johnson, Matthew S.
    Pacofsky, Gregory J.
    Thomas, James B.
    Carroll, William A.
    Krambis, Michael J.
    Liu, Dong
    Shieh, Char-Chang
    Zhang, XuFeng
    Hernandez, Gricelda
    Mikusa, Joseph P.
    Zhong, Chengmin
    Joshi, Shailen
    Honore, Prisca
    Roeloffs, Rosemarie
    Marsh, Kennan C.
    Murray, Bernard P.
    Liu, Jinrong
    Werness, Stephen
    Faltynek, Connie R.
    Krafte, Douglas S.
    Jarvis, Michael F.
    Chapman, Mark L.
    Marron, Brian E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) : 407 - 416
  • [5] Subtype-selective Nav1.8 sodium channel blockers: Identification of potent, orally active nicotinamide derivatives
    Kort, Michael E.
    Atkinson, Robert N.
    Thomas, James B.
    Drizin, Irene
    Johnson, Matthew S.
    Secrest, Matthew A.
    Gregg, Robert J.
    Scanio, Marc J. C.
    Shi, Lei
    Hakeem, Ahmed H.
    Matulenko, Mark A.
    Chapman, Mark L.
    Krambis, Michael J.
    Liu, Dong
    Shieh, Char-Chang
    Zhang, XuFeng
    Simler, Gricelda
    Mikusa, Joseph P.
    Zhong, Chengmin
    Joshi, Shailen
    Honore, Prisca
    Roeloffs, Rosemarie
    Werness, Stephen
    Antonio, Brett
    Marsh, Kennan C.
    Faltynek, Connie R.
    Krafte, Douglas S.
    Jarvis, Michael F.
    Marron, Brian E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6812 - 6815
  • [6] A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat
    Jarvis, Michael F.
    Honore, Prisca
    Shieh, Char-Chang
    Chapman, Mark
    Joshi, Shailen
    Zhang, Xu-Feng
    Kort, Michael
    Carroll, William
    Marron, Brian
    Atkinson, Robert
    Thomas, James
    Liu, Dong
    Krambis, Michael
    Liu, Yi
    McGaraughty, Steve
    Chu, Katharine
    Roeloffs, Rosemarie
    Zhong, Chengmin
    Mikusa, Joseph P.
    Hernandez, Gricelda
    Gauvin, Donna
    Wade, Carrie
    Zhu, Chang
    Pai, Madhavi
    Scanio, Marc
    Shi, Lei
    Drizin, Irene
    Gregg, Robert
    Matulenko, Mark
    Hakeem, Ahmed
    Grosst, Michael
    Johnson, Matthew
    Marsh, Kennan
    Wagoner, P. Kay
    Sullivan, James P.
    Faltynek, Connie R.
    Krafte, Douglas S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (20) : 8520 - 8525
  • [7] Discovery of Hbw-3-80, a Potent, Bioavailable Sodium Channel Nav.1.8 Blocker for Pain
    Yuan, Chester Chenguang
    ANNALS OF NEUROLOGY, 2021, 90 : S238 - S238
  • [8] 2-Aminopyridines as Potent and Selective Nav1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain Model
    Breslin, Michael J.
    Schubert, Jeffrey W.
    Wang, Deping
    Huang, Chienjung
    Clements, Michelle K.
    Li, Yuxing
    Zhou, Xiaoping
    Vardigan, Joshua D.
    Kraus, Richard L.
    Santarelli, Vincent P.
    Uslaner, Jason M.
    Coleman, Paul J.
    Stachel, Shawn J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 917 - 923
  • [9] Alt0181-conotoxin SIIIA selective inhibition of Nav1.8 sodium channels in rat dorsal root ganglion neurons with efficacy in inflammatory pain model
    Zhang H
    Wang C.-Z.
    Chi C-W
    Zhao Z.-Q
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 32 - 33
  • [10] Synthesis and biological evaluation of 1-(isoxazol-5-ylmethylaminoethyl)-4-phenyl tetrahydropyridine and piperidine derivatives as potent T-type calcium channel blockers with antinociceptive effect in a neuropathic pain model
    Lee, Ju-Hyeon
    Seo, Seon Hee
    Lim, Eun Jeong
    Cho, Nam-Chul
    Nam, Ghilsoo
    Kang, Soon Bang
    Pae, Ae Nim
    Jeong, Nakcheol
    Keum, Gyochang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 74 : 246 - 257